nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2020-24-6-55-64nefr-1901Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSВозможности использования фракционированных и нефракционированных гепаринов после первичного эндопротезирования тазобедренного и коленного суставов у пациентов, получающих программный гемодиализComparison of using fractionated and unfractionated heparins after primary hip and knee arthroplasty in patients receiving programmed hemodialysishttps://orcid.org/0000-0002-7264-7861МуштинН. Е.MushtinN. E.

Асс. Муштин Никита Евгеньевич, кафедра травматологии и ортопедии

197022, Санкт-Петербург, ул. Рентгена, д. 12, корп. 44Тел.: +7(812)338-65-07 

Assistant Nikita E. Mushtin, MD, PhD, Department of Traumatology and Orthopaedics

197022, Saint Petersburg, Rentgen str., 12, build. 44Phone: +7(812)338-65-07 

mushtin@yandex.ruhttps://orcid.org/0000-0001-8392-5380ЦедА. Н.TsedA. N.

Доц. Цед Александр Николаевич, кан. мед наук, кафедра травматологии и ортопедии

197022, Санкт-Петербург, ул. Рентгена, д. 12, корп. 44Тел.: +7(812)338-65-07 

Ass. prof. Aleksandr N. Tsed, MD, PhD, Department of Traumatology and Orthopaedics

197022, Saint Petersburg, Rentgen str., 12, build. 44Phone: +7(812)338-65-07 

tsed@mail.ruhttps://orcid.org/0000-0003-4079-5541ДулаевА. К.DulaevA. K.

Проф. Дулаев Александр Кайсинович, д-р мед наук, кафедра травматологии и ортопедии, заведующий

197022, Санкт-Петербург, ул. Рентгена, д. 12, корп. 44Тел.: +7(812)338-65-07 

Prof. Aleksandr K. Dulaev MD, PhD, DMedSci, Department of Traumatology and Orthopaedics

197022, Saint Petersburg, Rentgen str., 12, build. 44Phone: +7(812)338-65-07 

travma1@mail.ruhttps://orcid.org/0000-0003-0873-8264ЛеонтьеваН. В.LeontyevaN. V.

Проф. Леонтьева Наталия Владимировна, д-р мед. наук, кафедра внутренних болезней и нефрологии

195067, Санкт-Петербург, Пискаревский пр., д. 47, павильон 18Тел.: +7(812)543-05-86 

Prof. Natalia V. Leontyeva, MD, PhD, DMedSci, Department of Internal Medicine and Nephrology

195067, Saint Petersburg, Piskarevsky Ave 47, pavilion 18Phone: +7(812)543-05-86 

leontyevanv@mail.ruhttps://orcid.org/0000-0002-9455-1043РумянцевА. Ш.RumyantsevA. Sh.

Проф. Румянцев Александр Шаликович, д-р мед. наук, Санкт-Петербургский государственный университет, кафедра факультетской терапии; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова, кафедра пропедевтики внутренних болезней

199106, Санкт-Петербург, 21-я линия В.О., д. 8а197022, Санкт-Петербург, ул. Льва Толстого, д. 6–8Тел.: +7(812)326-03-26Тел.: +7(812)234-01-65 

Prof. Alexandr Sh.Rumyantsev, MD, PhD, DMedSci, Department of Faculty Therapy

199106, Saint Petersburg, V.O., 21 line 8aPhone: +7(812)326-03-26 

rash.56@mail.ruПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаРоссияPavlov UniversityRussian FederationСеверо-Западный государственный медицинский университет имени И.И. МечниковаРоссияNorth-West State Medical University named after I.I. MechnikovRussian FederationСанкт-Петербургский государственный университет; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаРоссияSaint Petersburg State University; Pavlov UniversityRussian Federation2020251120202465564Copyright © Муштин Н.Е., Цед А.Н., Дулаев А.К., Леонтьева Н.В., Румянцев А.Ш., 20202020Муштин Н.Е., Цед А.Н., Дулаев А.К., Леонтьева Н.В., Румянцев А.Ш.Mushtin N.E., Tsed A.N., Dulaev A.K., Leontyeva N.V., Rumyantsev A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1901эндопротезирование тазобедренного и коленного суставапрограммный гемодиализтромбопрофилактикаarthroplasty of the hip and knee jointsprogrammed hemodialysisthromboprophylaxisReferencesLiyanage T, Ninomiya T, Jha V et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015;385:1975-1982. doi: 10.1016/S0140-6736(14)61601-9Liyanage T, Ninomiya T, Jha V et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015;385:1975-1982. doi: 10.1016/S0140-6736(14)61601-9Отчет Общероссийского Регистра заместительной почечной терапии Российского диализного общества. 2018 год. http://nephro.ru/index.php?r=site/pageView&id=278%20,%20journal.nephro.ru/index.php?r=journal/pageView&id=278Report of the All-Russian Register of Renal Replacement Therapy of the Russian Dialysis Society. 2018 year. http://nephro.ru/index.php?r=site/pageView&id=278%20,%20journal.nephro.ru/index.php?r=journal/pageView&id=278Lin JC, Liang WM. Mortality and complications after hip fracture among elderly patients undergoing hemodialysis. BMC Nephrol 2015;16:100. doi: 10.1186/s12882-015-0099-0Lin JC, Liang WM. Mortality and complications after hip fracture among elderly patients undergoing hemodialysis. BMC Nephrol 2015;16:100. doi: 10.1186/s12882-015-0099-0Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol 2014; 3(3):99-104. doi: 10.12860/jnp.2014.19Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol 2014; 3(3):99-104. doi: 10.12860/jnp.2014.19Liao JN, Chao TF, Liu CJ et al. Incidence and risk factors for new-onset atrial fibrillation among patients with end stage renal disease undergoing renal replacement therapy. Kidney Int 2015; 87:1209-1215Liao JN, Chao TF, Liu CJ et al. Incidence and risk factors for new-onset atrial fibrillation among patients with end stage renal disease undergoing renal replacement therapy. Kidney Int 2015; 87:1209-1215Ng KP, Edwards NC, Lip GYH et al. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis 2013;62(3):615-632Ng KP, Edwards NC, Lip GYH et al. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis 2013;62(3):615-632Limdi NA, Nolin TD, Booth SL et al. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Am J Kidney Dis 2015;65:701-709. doi: 10.1053/j.ajkd.2014.11.004Limdi NA, Nolin TD, Booth SL et al. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Am J Kidney Dis 2015;65:701-709. doi: 10.1053/j.ajkd.2014.11.004Протокол ведения больных. Профилактика тромбоэмболии легочной артерии при хирургических и иных инвазивных вмешательствах. МЗ РФ Приказ №233 от 09.06.2003 г.Patient management protocol. Prevention of pulmonary thromboembolism during surgical and other invasive interventions. Ministry of Health of the Russian Federation Order No. 233 dated 09.06.2003.Jose MD, Longmuir H, Dodds B et al. Anticoagulation for people receiving long-term hemodialysis (protocol). Cochrane Database Syst Rev 2015;9:CD011858Jose MD, Longmuir H, Dodds B et al. Anticoagulation for people receiving long-term hemodialysis (protocol). Cochrane Database Syst Rev 2015;9:CD011858Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-478. doi: 10.1185/03007999609115227Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-478. doi: 10.1185/03007999609115227Nadler S, Hidalgo J, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51(2):224-232Nadler S, Hidalgo J, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51(2):224-232Ponnusamy KE, Jain A, Thakkar SC et al. Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty. J Bone Joint Surg Am 2015;97(16):1326-1332. doi: 10.2106/JBJS.N.01301Ponnusamy KE, Jain A, Thakkar SC et al. Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty. J Bone Joint Surg Am 2015;97(16):1326-1332. doi: 10.2106/JBJS.N.01301Cavanaugh PK, Chen AF, Rasouli MR et al. Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplast 2016;31(2):465-472. doi: 10.1016/j.arth.2015.09.003Cavanaugh PK, Chen AF, Rasouli MR et al. Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplast 2016;31(2):465-472. doi: 10.1016/j.arth.2015.09.003Mossey RT, Kasabian AA, Wilkes BM et al. Pulmonary embolism: low incidence in chronic renal failure. Arch Intern Med 1982;142:1646-1648Mossey RT, Kasabian AA, Wilkes BM et al. Pulmonary embolism: low incidence in chronic renal failure. Arch Intern Med 1982;142:1646-1648Alhenc-Gelas M, Rossert J, Jacquot C, Aiach M. Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome. Nephron 1995;71: 149-152Alhenc-Gelas M, Rossert J, Jacquot C, Aiach M. Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome. Nephron 1995;71: 149-152Hirsh J, Bauer KA, Donati MB et al. Parenteral Anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:141S-59SHirsh J, Bauer KA, Donati MB et al. Parenteral Anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:141S-59SPettigrew M, Soltys GI, Bell RZ et al. Tinzaparin reduces health care resource use for anticoagulation in hemodialysis. Hemodial Int 2011;15(2):273-279. doi: 10.1111/j.1542-4758.2011.00531.xPettigrew M, Soltys GI, Bell RZ et al. Tinzaparin reduces health care resource use for anticoagulation in hemodialysis. Hemodial Int 2011;15(2):273-279. doi: 10.1111/j.1542-4758.2011.00531.xThorevska N, Amoateng-Adjepong Y, Sabahi R et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 2004;125:856-863. doi: 10.1378/chest.125.3.856Thorevska N, Amoateng-Adjepong Y, Sabahi R et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 2004;125:856-863. doi: 10.1378/chest.125.3.856Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006;144(9):673-684Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006;144(9):673-684Lim W, Cook DJ, Crowther MA. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol 2004;15:3192-3206. doi: 10.1097/01.ASN.0000145014.80714.35Lim W, Cook DJ, Crowther MA. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol 2004;15:3192-3206. doi: 10.1097/01.ASN.0000145014.80714.35Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol 2011;7(9):499-508. doi: 10.1038/nrneph.2011.88Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol 2011;7(9):499-508. doi: 10.1038/nrneph.2011.88De Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and non-cardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-1789. doi: 10.1001/jama.2009.1488De Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and non-cardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-1789. doi: 10.1001/jama.2009.1488Tsai MH, Fang YU, Leu JG. Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study. SWJ 2014;486781Tsai MH, Fang YU, Leu JG. Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study. SWJ 2014;486781Akiba T, Tachibana K, Ozawa K et al. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients in hemodialysis. ASAIO Journal 1992;38(3):M326-M330Akiba T, Tachibana K, Ozawa K et al. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients in hemodialysis. ASAIO Journal 1992;38(3):M326-M330Leu J-G, Liou H-H, Wu S-C et al. Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis. Journal of the Formosan Medical Association 1998;97(1):49-54Leu J-G, Liou H-H, Wu S-C et al. Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis. Journal of the Formosan Medical Association 1998;97(1):49-54Elisaf MS, Germanos NP, Bairaktari HT et al. Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients. The American Journal of Nephrology 1997; 17(2):153-157Elisaf MS, Germanos NP, Bairaktari HT et al. Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients. The American Journal of Nephrology 1997; 17(2):153-157Bernieh B, Boobes Y, Al Hakim MR et al. Long-term use of low-molecular-weight heparin in hemodialysis patients: a 7-year experience. Blood Purification 2009;27(3):242-245. doi: 10.1159/000199429Bernieh B, Boobes Y, Al Hakim MR et al. Long-term use of low-molecular-weight heparin in hemodialysis patients: a 7-year experience. Blood Purification 2009;27(3):242-245. doi: 10.1159/000199429Resi´c H, Kukavica N, Sahovi´c V, Masni´c F. Different effects of low weight molecular heparin and unfractioned heparin on lipid profile and coagulation at haemodialysis patients. Bosnian Journal of Basic Medical Sciences 2010;10(supplement 1):S56-S62Resi´c H, Kukavica N, Sahovi´c V, Masni´c F. Different effects of low weight molecular heparin and unfractioned heparin on lipid profile and coagulation at haemodialysis patients. Bosnian Journal of Basic Medical Sciences 2010;10(supplement 1):S56-S62Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. The Lancet 2011; 377(9784): 2181-2192. doi: 10.1016/S0140-6736(11)60739-3Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. The Lancet 2011; 377(9784): 2181-2192. doi: 10.1016/S0140-6736(11)60739-3Salduz A, Polat G, Akgül T et al. Complications and midterm outcomes of hemiarthroplasty in hemodialysis patients. Acta Ortop Bras 2017;25(5):220-223. doi:10.1590/1413-785220172505167473Salduz A, Polat G, Akgül T et al. Complications and midterm outcomes of hemiarthroplasty in hemodialysis patients. Acta Ortop Bras 2017;25(5):220-223. doi:10.1590/1413-785220172505167473

The authors declare that there are no conflicts of interest present.